학술논문

Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth
Document Type
article
Source
Neoplasia. 18(5)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Immunology
Cancer
Rare Diseases
Aetiology
2.1 Biological and endogenous factors
Animals
Cell Movement
Cell Proliferation
Chemokines
Dendritic Cells
Disease Models
Animal
Endothelial Cells
Heparitin Sulfate
Humans
Immunophenotyping
Mice
Mice
Transgenic
Mutation
Neoplasms
Phenotype
Proteoglycans
Syndecan-4
Tumor Burden
Clinical Sciences
Oncology & Carcinogenesis
Clinical sciences
Oncology and carcinogenesis
Language
Abstract
In cancer, proteoglycans have been found to play roles in facilitating the actions of growth factors, and effecting matrix invasion and remodeling. However, little is known regarding the genetic and functional importance of glycan chains displayed by proteoglycans on dendritic cells (DCs) in cancer immunity. In lung carcinoma, among other solid tumors, tumor-associated DCs play largely subversive/suppressive roles, promoting tumor growth and progression. Herein, we show that targeting of DC glycan sulfation through mutation in the heparan sulfate biosynthetic enzyme N-deacetylase/N-sulfotransferase-1 (Ndst1) in mice increased DC maturation and inhibited trafficking of DCs to draining lymph nodes. Lymphatic-driven DC migration and chemokine (CCL21)-dependent activation of a major signaling pathway required for DC migration (as measured by phospho-Akt) were sensitive to Ndst1 mutation in DCs. Lewis lung carcinoma tumors in mice deficient in Ndst1 were reduced in size. Purified CD11c+ cells from the tumors, which contain the tumor-infiltrating DC population, showed a similar phenotype in mutant cells. These features were replicated in mice deficient in syndecan-4, the major heparan sulfate proteoglycan expressed on the DC surface: Tumors were growth-impaired in syndecan-4-deficient mice and were characterized by increased infiltration by mature DCs. Tumors on the mutant background also showed greater infiltration by NK cells and NKT cells. These findings indicate the genetic importance of DC heparan sulfate proteoglycans in tumor growth and may guide therapeutic development of novel strategies to target syndecan-4 and heparan sulfate in cancer.